Waiting For Pfizer: GSK Will Cut Sales Force Should Pfizer Act First

14 Feb 2005

• By The Pink Sheet

GlaxoSmithKline will reduce the size of its sales force and reinvest those expenditures in research and development should Pfizer decide to downsize its sales team, GSK CEO J.P. Garnier said

Waiting For Pfizer: GSK Will Cut Sales Force Should Pfizer Act First

More from Archive

More from Pink Sheet